| Factor Information | |
|---|---|
| Data ID | 1455 |
| Factor | plasma CTGF |
| Description | N/A |
| Biomarker | YES |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | children with CHD |
| p Value | <0.01 |
| Conclusion | Plasma CTGF levels were significantly higher in cyanotic PAH-CHD group than in CHD group |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 530 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | VSD/PDA/ASD/VSD, PDA/DORV/AVSD/ECD/TAPVR |
| Reference | |
|---|---|
| PMID | 26714814 |
| Year | 2017 |
| Title | Elevated Plasma Connective Tissue Growth Factor Levels in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease. |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | blood | |
| Region | Luzhou, China | |
| Method | The Mann-Whitney U test | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | cyanotic PAH-CHD(Treatment) | CHD(Control) |
| Number | 13 | 30 |
| Age | 53.7±38.8 months(PAH-CHD) | 53±34.6 months(CHD) |
| Gender (Male: Female) | N/A | 11:19 |
| Marker Level | 1956.5±506.5pmol/L | 1123.7±344.9pmol/L |
